SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001477932-14-002681
Filing Date
2014-05-16
Accepted
2014-05-16 11:56:59
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A ctix_10qa.htm 10-Q/A 47621
2 CERTIFICATION ctix_ex311.htm EX-31.1 16985
3 CERTIFICATION ctix_ex312.htm EX-31.2 16258
4 CERTIFICATION ctix_ex321.htm EX-32.1 7321
5 CERTIFICATION ctix_ex322.htm EX-32.2 8400
  Complete submission text file 0001477932-14-002681.txt   5072393

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ctix-20140331.xml EX-101.INS 722550
7 XBRL INSTANCE DOCUMENT ctix-20140331.xsd EX-101.SCH 82054
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctix-20140331_cal.xml EX-101.CAL 61979
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctix-20140331_def.xml EX-101.DEF 266427
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctix-20140331_lab.xml EX-101.LAB 441988
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctix-20140331_pre.xml EX-101.PRE 331354
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 000-52321 | Film No.: 14850408
SIC: 2834 Pharmaceutical Preparations